MAPT and tauopathy: Neutralizing pathological tau with a vaccine or genetic deficiency of inflammasomes reduced IL-1β activation, neuroinflammation, tau hyperphosphorylation, and improved memory in different mouse models of tauopathy (Jiang et al., 2021; Maphis et al., 2025).